Updated Date: Mon, 02 Aug 2021 00:00:00 EDT

Sanofi notches another Pompe win with FDA blessing for enzyme replacement therapy Nexviazyme fkansteiner Fri, 08/06/2021 – 14:44

From vaccine halo to liability? Reputation tracker says COVID-19 shot makers now dinged for safety, supply issues bbulik […]

From a collection of molecules inspired by anti-parasitic medicines comes a potential drug candidate against COVID-19.

Pooled results from phase 3 clinical trials demonstrate that roxadustat is efficacious and may be comparable to placebo […]

A team of researchers has developed an immunotherapy strategy that can eliminate pancreatic tumors in mice. The new […]

Salisbury wonders whether presumed consent is enough for sharing medical data and concludes that data sharing needs a […]

Junior doctors in England will be surveyed on whether they wish to consider any form of action over […]

Sheila Cameron Fowler started her career as a GP in the early 1960s as an assistant to Dr […]

Sanofi and Regeneron solidify Dupixent TV ad lead, topping July pharma spenders again, trailed by AbbVie and Novo […]